CVS Health (NYSE:CVS) Lowered to "Market Perform" at Leerink Partnrs
CVS Health (NYSE:CVS – Get Free Report) was downgraded by Leerink Partnrs from an “outperform” rating to a “market perform” rating in a research note issued to investors on Wednesday, Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s Q4 2024 earnings at $1.94 EPS and FY2027 earnings at $9.68 EPS. Several other research […]